Cold Chain Technologies enables ocean freight breakthrough for Teva and Kuehne+Nagel

Cold Chain Technologies (CCT) has successfully demonstrated that sea freight can be a reliable, cost-effective, and sustainable alternative to air transport for high-value pharmaceutical products, following a landmark project with Kuehne+Nagel and Teva Pharmaceuticals. The project validated the transportation of temperature-sensitive medicines from Germany to Australia, one of the world’s most demanding sea routes. Despite […]

The post Cold Chain Technologies enables ocean freight breakthrough for Teva and Kuehne+Nagel appeared first on Container News.